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558a Tuesday, February 28, 2012cMyBP-C is altered during heart failure (HF). There are several identified phos-
phorylated residues, including the regulatory phosphorylation sites Ser275,
Ser284 and Ser304. Methods: Comparison of the extent of MyBP-C phosphor-
ylation status in failing (N=10) and non-failing (N=10) human left ventricle
(LV) tissue. The myofilament subproteome was extracted using the ‘IN Se-
quence’ method prior to analysis with some samples dephosphorylated using
alkaline phosphatase as control. Sample analysis was carried out using gel-
(e.g. phos-tag) and mass spectrometry (MS)-based methods. Results: Using
an MS-based phospho-peptide (Ti02 chromatography) enrichment strategy
we identified novel phosphorylation sites at residues Ser286 and Thr290, lo-
cated in the M-motif. These sites were as well observed in MyBP-C from
LV canine hearts. A novel site at residue Thr1109, the titin binding domain
C9, was only observed in the samples without phospho-enrichment. Our results
indicate a marked reduction in cMyBP-C phosphorylation at residues Ser284,
Ser286, Thr290 and Thr1109 in end-stage HF compared to the non-failing
group. Conclusion: This study provides evidence for novel phosphorylation
sites on cMyBP-C both in human and canine hearts and reduced phosphoryla-
tion levels in the end-stage failing heart.
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Recombinant N-terminal domains of cardiac myosin binding protein C
(cMyBP-C) increase calcium-sensitivity of force and the rate of tension rede-
velopement (ktr) when added to permeabilized rat trabeculae. We previously
demonstrated that the regulatory domain of cMyBP-C, referred to as the
MyBP-C motif (or ‘‘M domain’’), is required for these effects. Here we inves-
tigated the effects of single amino acid missense substitutions within the M-do-
main that are associated with human hypertrophic cardiomyopathy (HCM) on
force development and ktr in permeabilized trabeculae from rat right ventricles.
Individual substitutions (R322Q, E330K, V338D, and L348P) were introduced
into a recombinant mouse C1C2 protein (encompassing domains C1-M-C2 of
murine cMyBP-C) by site directed mutagenesis and effects were compared to
wild-type C1C2. All four of the mutations affected the ability of C1C2 to aug-
ment force. Whereas 5 mM wild-type C1C2 induced a pronounced leftward
shift in Ca2þ sensitivity of tension (~0.5 pCa units) and increased ktr at all sub-
maximal Ca2þ concentrations, 3 of the mutations reduced the effects of C1C2.
Another variant increased the efficacy of C1C2 and increased passive force in-
dependent of Ca2þ, but reduced maximal Ca2þ activated force. Together
these results indicate that cMyBP-C variants associated with HCM could di-
rectly disrupt sarcomere contractile properties through gain or loss of func-
tional effects and that at least some cMyBP-C missense mutations may cause
disease through a poison polypeptide mechanism. This work is supported by
NIH HL080367 to SPH and a DOD NDSEG graduate fellowship to KLB.
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Cardiac myosin binding protein-C (cMyBP-C) is a member of the immuno-
globulin (Ig) superfamily of proteins and consists of 8 Ig- and 3 fibronectin
(Fn)-like domains along with a unique regulatory sequence referred to as the
MyBP-C ‘‘motif’’ or M-domain. Previously we used atomic force microscopy
(AFM) to investigate the mechanical properties of the different domains of mu-
rine cMyBP-C expressed using a baculovirus/insect cell expression system. To
investigate whether the mechanical properties of cMyBP-C are conserved
across species, here we used AFM to investigate the mechanical properties
of human recombinant cMyBP-C expressed using a baculovirus/insect cell
expression system and native cMyBP-C purified from bovine heart. AFM
force-extension spectra were obtained from cMyBP-C molecules by randomly
adhering individual molecules to the tip of an AFM cantilever and moving the
cantilever to impose a load that stretched the molecules. Results show that the
spectra for the human recombinant and bovine native proteins are remarkably
similar with the first Ig/Fn-like domain unfolding events occurring at low
(~50 pN) forces and the highest stability domains unfolding at ~190 pN. Exper-
iments also revealed frequent unfolding events that appeared coupled such that
lower stability domains would often unfold after higher stability domains.
These unexpected force ‘‘drops’’ were highly reproducible and occurred in
spectra from both human cMyBP-C and bovine cMyBP-C. In addition, both re-
combinant and native cMyBP-C exhibited an ~100 nm long extensible regionthat could be stretched with less than 50 pN force prior to the unfolding of Ig
and Fn-like domains. Combined with our previous results from mouse cMyBP-
C, these results establish common mechanical features of cMyBP-C across spe-
cies. Supported by NIH HL080367.
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Cardiac myosin binding protein-C (cMyBP-C) is a modular protein involved in
stabilizing interactions with the thick filament of the sarcomere. The N-termi-
nus of cMyBP-C associates with actin and myosin S2 and the C-terminus inter-
acts with titin and myosin rods. While no high-resolution structure of C-
terminal cMyBP-C exists, disruption of this region is proposed to destabilize
cMyBP-C and adversely affect cardiac structure and function. In particular, de-
letion of 25 base pairs (D25) in the gene encoding for cMyBP-C results in
amino acid substitutions in the C10 domain of cMyBP-C (C10 D25) which
may be associated with the development of hypertrophic and dilated cardiomy-
opathies by unknown molecular mechanisms. The prevalence of this mutation
is approximately 1% of the world population, underscoring the necessity of de-
termining its role(s) in the pathogenesis of cardiomyopathies. In this study, cir-
cular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopies
have been used to examine the conformation of wild-type (Wt) and mutant
C-terminal domains of cMyBP-C. Comparison of near UV CD spectra revealed
alterations in the packing of aromatic residues in C10 D25 suggesting it is less
stably folded as compared to C10 Wt. C10 D25 exhibited less beta-sheet con-
tent than C10 Wt as evidenced by the estimation of secondary structure from
CD data. NMR analyses of amide proton/nitrogen chemical shifts and line-
widths were used to probe the conformation of C10 domains and to map resi-
dues of importance in protein-protein association onto cMyBP-C models.
Taken together, these data suggest that theD25 mutation structurally modulates
cMyBP-C sites involved in binding titin and myosin.
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Phosphodiesterase (PDE4DE): Implications for a Possible Role in Heart
Failure
Abeer Rababa’h, John Craft, Cori Wijaya, Bradley K. McConnell.
University of Houston, Houston, TX, USA.
Heart failure is a leading cause of morbidity and mortality in the USA. There
are several therapeutic agents available for heart failure management. In partic-
ular, agents that block beta-adrenergic receptor improve mortality rate among
heart failure patients by enhancing cardiac function. Beta-adrenergic receptor
stimulation signals through protein kinase A (PKA) dependent phosphoryla-
tion, partly by binding to A-kinase anchoring proteins, influencing calcium ho-
meostasis. In particular, mAKAP (muscle-selective A-kinase anchoring
protein) is targeted to specific intracellular compartments resulting in localiza-
tion of PKA with its substrates as well as to bind with ryanodine receptors and
phosphodiesterase-4D3 (PDE4DE). The signal transduction complex formed
by the scaffold protein mAKAP at the perinuclear envelop of striated myocytes
contains cAMP specific binding protein PDE4D3 which is responsible for
cAMP signaling termination. Agents that modify PKA signaling would be ex-
pected to mediate an altered inotropic response. From different genomic data-
bases, we have recently identified fifteen human mAKAP coding non-
synonymous polymorphisms located within or near key protein binding sites
critical to beta-adrenergic receptors signaling. Seven of these mutants were
cloned for the purpose of comparing whether those substitution disrupt mA-
KAP binding to either the PKA binding domain R2alpha or the phosphodiester-
ase PDE4DE. Using surface plasmon resonance (Biacore 2000) we
demonstrate specific binding of wild type mAKAP to PDE4DE. Experiments
were run in triplicate and as twofold serial dilutions to explore the kinetics
of the interaction and analyzed using Scrubber2 with a 1:1 Langmuir model.
Comparative analysis of the binding responses of mutations to mAKAP could
provide important information about how these mutations modulate signaling.
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Recently, a mutation in the 10th immunoglobulin(Ig)-like domain in
titin’s elastic I-band was found in a family affected with arrhythmogenic
Tuesday, February 28, 2012 559acardiomyopathy (AC). AC is characterized by fibrofatty replacement of myo-
cardium, which can lead to fatal ventricular arrhythmias. Titin is a gigantic
sarcomeric protein that is responsible for passive tension development in
stretched cardiac muscle. We investigated the effect that the AC-linked point
mutation (T16I in Ig10) has on the mechanical and kinetic stability of Ig10 us-
ing single molecule force spectroscopy (AFM) and degradation assays. Our
AFM data indicate that T16I Ig10 unfolds at a lower force than WT Ig10,
which shows that it is mechanically less stable. We also performed force
clamp and refolding experiments with AFM and found that the unfolding
rate of T16I Ig10 is four times higher than WT Ig10 (.02/s vs. .005/s at zero
force), but that this difference is further increased in a force-dependent man-
ner; refolding rates were found to be similar. We also performed degradation
assays with the protease tryspin to determine if the T16I mutation affects the
highly-stable beta barrel tertiary structure typical of Ig domains. We found that
T16I Ig10 has a greater proteolytic susceptibility compared to WT Ig10, and
subsequent mass spectrometry analysis determined that the primary cleavage
site in T16I Ig10 is the lysine residue that flanks T16I (K17). This strongly
suggests that the disease-linked titin mutation disrupts the local structure of
Ig10 in the vicinity of T16, which leaves Ig10 vulnerable to cleavage. Peptide
bond breakage anywhere along titin’s elastic region (which includes Ig10)
would likely abolish titin’s ability to generate force and lead to severe physi-
ological responses.
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Titin is widely considered the main contributor to passive stiffness of cardiac
myocytes. To test this we studied a novel mouse model, in which a large frac-
tion of titin’s proximal tandem Ig segment is deleted (we refer to the model as
IG KO; for details on model, see Chung et al poster). The proximal tandem Ig
segment extends greatly under physiological conditions and shortening the tan-
dem Ig segment is predicted to increase titin-based passive tension. We first
studied passive tension in skinned cardiac myocytes by stretching cells in relax-
ing solution with a velocity of 1 base-length/s (~in vivo speed during diastole),
and determining stiffness from the slope of the passive stress - SL relation in the
physiological SL range of 1.95-2.10 mm. Cellular stiffness was significantly in-
creased in the IG KO by ~50%. Using a sinusoidal analysis, the elastic moduli
at physiological SLs were found to be increased in the IG KO but the viscous
moduli were not different. This shows that the tandem Ig segment is a pure elas-
tic spring. Currently we are investigating intact myocytes using a carbon-fiber
based system for attaching cells and measuring force. We conclude that the-
proximal Ig segment of titin’s I band region is a pure elastic spring and that
shortening of this spring element increases titin-based cellular stiffness in the
physiological SL range. Increased titin-based stiffness is found in patients
with heart failure with preserved ejection fraction (HFpEF) and the IGKO is
well-suited to study the effect of increased titin-based stiffness on heart func-
tion (see poster by Chung et al).
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Titin is phosphorylated by several kinases that significantly affect titin me-
chanical properties. PKA and PKG phosphorylates titin N2B element and de-
creases titin’s stiffness, while PKCa phosphorylates titin PEVK spring
element and increases titin’s stiffness. CaMKII is a Ca2þ and calmodulin de-
pendent serine/threonine kinase that is activated by increases in cellular Ca2þ.
Four isoforms have been described (a, b, g, and d). CaMKII delta (CaMKIId)
is the predominant isoform in the heart. It has been found that increases in
CaMKIId activity causes severe left ventricular dysfunction. The aim of the
present study is to determine whether CaMKIId phosphorylates titin and, if
so, identify its target domains. To determine whether CaMKIId phosphory-
lates titin in mouse left ventricular muscle, LV skinned fibers were incubated
with recombinant human CaMKIId expressed in insect cells and [g-32P]ATP.We found that CaMKIId phosphorylates titin in mouse LV skinned fibers.
Further, pre-incubation of the LV skinned fiber with protein phosphatase 1
(PP1) significantly increases 32P incorporation on titin. To identify the CaM-
KIId titin target domains, human titin N2B, PEVK, Ig8-15, I27-34, and mu-
rine N2B recombinant proteins expressed in E. coli were incubated with
CaMKIId and [g-32P]ATP. We found that titin N2B and PEVK spring ele-
ments, but not Ig domains, were phosphorylated by CaMKIId. Prediction of
the specific phosphorylation sites suggest overlap with the PKC and PKA sites
(including S170 of the PEVK element a PKC substrate) and work to indentify
the specific substrate sites and the possible effect on mechanics is in progress.
In summary, the present study showed that CaMKIId phosphorylates titin
spring elements.
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Thyroid hormone levels play an important role in cardiac regulation, and
a state of hypothyroidism leads to dilated forms of cardiomypathy. Inappropri-
ate thyroid levels can also impact the sarcomeric protein titin, which is re-
sponsible for maintaining passive tension and structural integrity. The
effects of hypothyroidism were studied after administration of propylthioura-
cil (PTU) to wild type (Wt) and homozygous mutant (Hm) rats (Greaser et al J
Mol Cellul Cardiol 44:983, 2008) (the latter of which express a giant titin iso-
form). Enzyme-linked immunosorbent assay results demonstrated that PTU
lowered thyroxine levels in the treated rats. Electrophoretic cardiac myosin
heavy chain analysis indicated that hypothyroidism induced a transition to
predominantly beta myosin heavy chain expression, while Wt control samples
continued to express an age-appropriate range of alpha and beta isoforms.
PTU-treated Wt rats had a larger N2BA to N2B titin ratio, and the slower mi-
grating N2BA was in higher proportion than the faster N2BA. PTU did not
affect titin isoform expression in Hm. Because it is believed that thyroid hor-
mone regulates titin isoform expression through the PI3K/Akt pathway, we in-
vestigated several participants by immunoblotting. The Akt PH domain was
not altered by PTU administration, although expression was higher in Hm
rats. Akt phospho-Ser473 did not vary between treatments, but mTOR
phospho-Ser2448 demonstrated a higher phosphorylation state in Wt. Echo-
cardiography data showed significantly decreased fractional shortening in
Hm control, Hm PTU, and Wt PTU relative to Wt control. Wt control also
exhibited a higher ejection fraction and a lower isovolumic relaxation time
compared to the other treatments. It can be concluded that hypothyroidism
has significant effects on titin isoform expression and other cardiac functional
characteristics. Supported by NIH HL77196.
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ABSTRACT
Volume overload (VO) heart failure occurs due to pathologies such as mitral
valve regurgitation, infarcts and ventricular septal defects, and leads to char-
acteristic eccentric dilation. Changes in passive myocardial stiffness are not
well understood and here we dissected the contribution of extracellular ma-
trix (ECM)-based and titin-based stiffness to overall passive stiffness. Titin
is a giant protein that regulates passive tension and hence diastolic function
in the myocardium. In heart failure, differential splicing and phosphorylation
events can occur that alter the stiffness of this protein and influence hemody-
namics. Increased diastolic stiffness due to differential splicing and phosphor-
ylation of titin has been observed in pressure overload hypertrophy; however,
there are no published studies investigating whether pure LV VO during
compensated heart failure leads to changes in titin based passive stiffness.
We studied the role of titin in modulating diastolic function in VO induced
by aortocaval fistula (ACF) in the mouse. ACF was induced in three-month-
old male C57BL/6 animals and allowed to progress for 12 weeks. At 12
weeks, echocardiography confirmed the presence of eccentric dilation and de-
creased systolic function as expected. Tissues were obtained from control and
VO hearts for mechanical measurements and protein studies. Skinned muscle
mechanics indicated an increase in both titin and ECM based passive based
stiffness; we are currently investigating the molecular basis of the changes in
titin. In summary, VO causes an increase in passive stiffness to which titin
contributes.
